ABCL
Price
$2.89
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
6 days until earnings call
ARVN
Price
$27.12
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
Ad is loading...

ABCL vs ARVN

Header iconABCL vs ARVN Comparison
Open Charts ABCL vs ARVNBanner chart's image
AbCellera Biologics
Price$2.89
Change-$0.00 (-0.00%)
Volume$2.85M
CapitalizationN/A
Arvinas
Price$27.12
Change-$0.00 (-0.00%)
Volume$887.41K
CapitalizationN/A
View a ticker or compare two or three
ABCL vs ARVN Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ABCL vs. ARVN commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and ARVN is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ABCL: $2.89 vs. ARVN: $27.12)
Brand notoriety: ABCL and ARVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 141% vs. ARVN: 145%
Market capitalization -- ABCL: $766.13M vs. ARVN: $1.69B
ABCL [@Biotechnology] is valued at $766.13M. ARVN’s [@Biotechnology] market capitalization is $1.69B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileARVN’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • ARVN’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 5 TA indicator(s) are bullish while ARVN’s TA Score has 6 bullish TA indicator(s).

  • ABCL’s TA Score: 5 bullish, 5 bearish.
  • ARVN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а +4.33% price change this week, while ARVN (@Biotechnology) price change was +5.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 25, 2025.

ARVN is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($1.69B) has a higher market cap than ABCL($766M). ARVN YTD gains are higher at: -34.111 vs. ABCL (-49.387). ABCL has higher annual earnings (EBITDA): -195.18M vs. ARVN (-364.2M). ARVN has more cash in the bank: 1.23B vs. ABCL (670M). ARVN has less debt than ABCL: ARVN (2.1M) vs ABCL (72.1M). ARVN has higher revenues than ABCL: ARVN (93.3M) vs ABCL (33.1M).
ABCLARVNABCL / ARVN
Capitalization766M1.69B45%
EBITDA-195.18M-364.2M54%
Gain YTD-49.387-34.111145%
P/E RatioN/AN/A-
Revenue33.1M93.3M35%
Total Cash670M1.23B55%
Total Debt72.1M2.1M3,433%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLARVN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 20 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ARVN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with DNA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
+6.25%
DNA - ABCL
58%
Loosely correlated
+1.35%
PRME - ABCL
57%
Loosely correlated
+4.47%
ADPT - ABCL
56%
Loosely correlated
+4.94%
NTLA - ABCL
56%
Loosely correlated
+2.45%
VCYT - ABCL
56%
Loosely correlated
+3.30%
More

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ABCL. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+4.63%
ABCL - ARVN
55%
Loosely correlated
+6.25%
IPSC - ARVN
50%
Loosely correlated
+0.72%
CRBU - ARVN
49%
Loosely correlated
+6.21%
KYMR - ARVN
47%
Loosely correlated
+2.27%
AXON - ARVN
46%
Loosely correlated
+0.06%
More